Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

NCT02238275 ·Status: COMPLETED

Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

NCT02242370 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

NCT00257491 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

NCT02242383 ·Status: COMPLETED

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

NCT02242344 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

NCT02177422 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension

NCT02242357 ·Status: COMPLETED

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

NCT02262611 ·Status: COMPLETED

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension

NCT00281580 ·Status: COMPLETED ·Phase: PHASE3

Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

NCT02243566 ·Status: COMPLETED

Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan

NCT01108796 ·Status: COMPLETED

Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

NCT02242864 ·Status: COMPLETED

Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

NCT00904371 ·Status: COMPLETED

Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients

NCT01108809 ·Status: COMPLETED

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

NCT00133185 ·Status: COMPLETED ·Phase: PHASE3

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

NCT00946829 ·Status: COMPLETED

Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)

NCT02175355 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension

NCT02269176 ·Status: COMPLETED ·Phase: PHASE3

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

NCT02242396 ·Status: COMPLETED

A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

NCT02200640 ·Status: COMPLETED ·Phase: PHASE4

Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

NCT02620163 ·Status: COMPLETED ·Phase: PHASE3

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

NCT05223101 ·Status: UNKNOWN ·Phase: PHASE1

An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

NCT00982735 ·Status: COMPLETED

Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects

NCT02262572 ·Status: COMPLETED ·Phase: PHASE1

Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

NCT00274612 ·Status: COMPLETED ·Phase: PHASE4